tiprankstipranks
Trending News
More News >
Fulcrum Therapeutics (FULC)
NASDAQ:FULC
US Market

Fulcrum Therapeutics (FULC) Revenue

Compare
515 Followers

Fulcrum Therapeutics Revenue

Fulcrum Therapeutics had a revenue of 0.00 in the quarter ending Sep 30, 2025, with ―. This bring the company's revenue in the last twelve months to 0.00, Decreased ―. In the fiscal year ending Dec 31, 2024, Fulcrum Therapeutics had annual revenue of 80.00M with 2752.05% growth.
Revenue (ttm)
0.00
Revenue Growth
-100.00%
P/S Ratio
9.96
Revenue/Employee
$1,777,778
Employees
45
Market Cap
$796.92M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
80.00M77.19M+2,852.05%
Dec 31, 2023
2.81M-3.54M+44.23%
Dec 31, 2022
6.34M-12.82M+33.10%
Dec 31, 2021
19.16M10.34M+217.19%
Dec 31, 2020
8.82M-882,300,000.00%
Dec 31, 2019
Dec 31, 2018
Dec 31, 2017